Biblio
Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Haematopoietic Stem Cell Transplant Recipients: A Cohort Study. Transplant Cell Ther. 2022.
Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing. Am J Hematol. 2023.
. Exagamglogene Autotemcel for Severe Sickle Cell Disease. N Engl J Med. 2024.
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia. N Engl J Med. 2024.
Feasibility of collecting umbilical cord blood in jordan and the effect of maternal and neonatal factors on hematopoietic stem cell content. Mediterr J Hematol Infect Dis. 2014;6(1):e2014019.
. .